Skip to main content
. 2024 Sep 30;10:35. doi: 10.1186/s40813-024-00383-9

Fig. 3.

Fig. 3

Anti-GnRF antibody results by treatment, study day and study (U/mL). (A) represents the results from the pre-clinical study, (B) from the 1st clinical study, and (C) from the 2nd clinical study. Points represent means ± SE. Points with an asterisk differ (P < 0.05) from the control group